CS260899B1 - Remedy for gastrointestinal diseases - Google Patents

Remedy for gastrointestinal diseases Download PDF

Info

Publication number
CS260899B1
CS260899B1 CS868061A CS806186A CS260899B1 CS 260899 B1 CS260899 B1 CS 260899B1 CS 868061 A CS868061 A CS 868061A CS 806186 A CS806186 A CS 806186A CS 260899 B1 CS260899 B1 CS 260899B1
Authority
CS
Czechoslovakia
Prior art keywords
formula
compound
cyclo
physiologically active
gastric
Prior art date
Application number
CS868061A
Other languages
Czech (cs)
English (en)
Other versions
CS806186A1 (en
Inventor
Evzen Kasafirek
Vaclav Plaisner
Libuse Korbova
Jiri Kohout
Jirina Cizkova
Ivan Krejci
Arnost Pospisil
Milan Pesak
Antonin Sturc
Jiri Krepelka
Antonin Dlabac
Jiri Vanzura
Original Assignee
Evzen Kasafirek
Vaclav Plaisner
Libuse Korbova
Jiri Kohout
Jirina Cizkova
Ivan Krejci
Arnost Pospisil
Milan Pesak
Antonin Sturc
Jiri Krepelka
Antonin Dlabac
Jiri Vanzura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evzen Kasafirek, Vaclav Plaisner, Libuse Korbova, Jiri Kohout, Jirina Cizkova, Ivan Krejci, Arnost Pospisil, Milan Pesak, Antonin Sturc, Jiri Krepelka, Antonin Dlabac, Jiri Vanzura filed Critical Evzen Kasafirek
Priority to CS868061A priority Critical patent/CS260899B1/cs
Priority to JP62273607A priority patent/JPH0832630B2/ja
Priority to EP87115997A priority patent/EP0268868A3/fr
Publication of CS806186A1 publication Critical patent/CS806186A1/cs
Publication of CS260899B1 publication Critical patent/CS260899B1/cs
Priority to US07/507,087 priority patent/US5182285A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS868061A 1986-11-07 1986-11-07 Remedy for gastrointestinal diseases CS260899B1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CS868061A CS260899B1 (en) 1986-11-07 1986-11-07 Remedy for gastrointestinal diseases
JP62273607A JPH0832630B2 (ja) 1986-11-07 1987-10-30 胃腸病の治療用組成物
EP87115997A EP0268868A3 (fr) 1986-11-07 1987-10-30 Compositions pharmaceutiques pour le traitement des maladies gastro-intestinales
US07/507,087 US5182285A (en) 1986-11-07 1990-04-06 Cell-protective composition for preventing or treating of peptic ulcer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS868061A CS260899B1 (en) 1986-11-07 1986-11-07 Remedy for gastrointestinal diseases

Publications (2)

Publication Number Publication Date
CS806186A1 CS806186A1 (en) 1988-06-15
CS260899B1 true CS260899B1 (en) 1989-01-12

Family

ID=5430708

Family Applications (1)

Application Number Title Priority Date Filing Date
CS868061A CS260899B1 (en) 1986-11-07 1986-11-07 Remedy for gastrointestinal diseases

Country Status (3)

Country Link
EP (1) EP0268868A3 (fr)
JP (1) JPH0832630B2 (fr)
CS (1) CS260899B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1236726B1 (fr) 1999-12-03 2004-12-01 Ono Pharmaceutical Co., Ltd. Derives triazaspiro 5.5]undecane et medicaments contenant ces derives en tant que principe actif
WO2014019556A1 (fr) * 2012-08-02 2014-02-06 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Alaptide : procédé de solubilisation, et de modification de la perméation membranaire, et compositions pharmaceutiques pour applications humaines et/ou vétérinaires

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1603030A (fr) * 1968-06-04 1971-03-15
JPS60248618A (ja) * 1984-05-24 1985-12-09 Nippon Zoki Pharmaceut Co Ltd ジペプチドを含有する潰瘍治療剤

Also Published As

Publication number Publication date
EP0268868A2 (fr) 1988-06-01
JPH0832630B2 (ja) 1996-03-29
CS806186A1 (en) 1988-06-15
EP0268868A3 (fr) 1990-05-09
JPS63130534A (ja) 1988-06-02

Similar Documents

Publication Publication Date Title
US4556678A (en) Sustained release propranolol tablet
TW580398B (en) Effervescent formulations
JPH08337526A (ja) 医薬組成物およびその製法
EP4122483A1 (fr) Composition pharmaceutique orale
JP2002501015A (ja) リーシュマニア症の治療における経口投与のためのミルテフォシンを含有する固形医薬品
JP3586471B2 (ja) トラセミド含有医薬組成物
EP1021087A1 (fr) Procede d'elaboration d'une preparation orale contenant de la serotonine, et methodes d'utilisation associees
UA73316C2 (uk) Фармацевтичний засіб, що містить похідну бензаміду як активний інгредієнт
JPS61268624A (ja) 抗高血圧症および心臓保護作用を有する医薬調剤
JPS5938203B2 (ja) 補酵素ｑを主成分とする脳循環障害治療剤
NO822385L (no) Terapeutisk preparat.
EP0393909A1 (fr) Composition
RU2240784C1 (ru) Лекарственное средство на основе арбидола
CS260899B1 (en) Remedy for gastrointestinal diseases
EP0604853A2 (fr) Composition pharmaceutique pour la prévention ou le traitement de l'artériosclérose
JP2001508769A (ja) アレンドロン酸塩及び胃排出を促進する薬剤を含有する医薬組成物
EP2968117A1 (fr) Procédé de traitement de déficience en vitamine b12
FI89455C (fi) Foerfarande foer framstaellning av en farmaceutisk komposition
RU2358723C1 (ru) Средство, обладающее антипохмельным действием, биологически активная добавка, фармацевтическая композиция, лекарственное средство и способ получения
US5182285A (en) Cell-protective composition for preventing or treating of peptic ulcer
JPH09501680A (ja) Ｈ▲下２▼−アンタゴニストの経口組成物
HU200685B (en) Process for producing combination pharmaceutical composition suitable for treating hypertension
US3932652A (en) Antidepressant compositions
US5216019A (en) Pain killer
US4510153A (en) Treatment of panic disorders with adinazolam